These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15803642)

  • 1. [Complication after implantable cardioverter defibrillator implantation: report of 1 case].
    Lou ZY; Zhou MH; Li XQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):360. PubMed ID: 15803642
    [No Abstract]   [Full Text] [Related]  

  • 2. Implantable cardioverter/defibrillators (ICDs).
    Med Lett Drugs Ther; 1994 Sep; 36(932):86-8. PubMed ID: 8084305
    [No Abstract]   [Full Text] [Related]  

  • 3. Superior vena cava syndrome and syncope in an implantable cardioverter defibrillator recipient.
    Kostopoulou A; Sbarouni E; Livanis EG; Theodorakis GN; Kremastinos D
    Europace; 2004 May; 6(3):205-8. PubMed ID: 15121071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines for cardioverter defibrillator implantation].
    Andrade JC; Avila Neto V; Braile DM; Brofman PR; Costa AR; Costa R; Galvão Filho SS; Gauch PR; Lucchese FA; Martinelli Filho M; Medeiros PT; Mateos JC; Pimenta J; Takeda RT
    Arq Bras Cardiol; 2000 May; 74(5):481-2. PubMed ID: 10951840
    [No Abstract]   [Full Text] [Related]  

  • 5. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 6. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

  • 7. Inappropriate implantable cardioverter-defibrillator shock due to external alternating current leak: report of two cases.
    Chan NY; Wai-Ling Ho L
    Europace; 2005 Mar; 7(2):193-6. PubMed ID: 15763537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal outcome from inappropriate defibrillation.
    Dimitri H; John B; Young GD; Sanders P
    Europace; 2007 Nov; 9(11):1059-60. PubMed ID: 17827163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-fatal incident on routine induction of ventricular fibrillation at the replacement of an implantable cardioverter defibrillator.
    Kolb C; Zrenner B; Schmitt C
    Int J Cardiol; 2006 Oct; 112(3):e74-5. PubMed ID: 16859778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
    Rahimtoola SH
    Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
    [No Abstract]   [Full Text] [Related]  

  • 11. Can incremental innovation of implantable cardioverter-defibrillator systems become disruptive to patient care? Moore's law gone awry.
    Naccarelli GV
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):621-2. PubMed ID: 16836710
    [No Abstract]   [Full Text] [Related]  

  • 12. Lead system causing twiddler's syndrome in patients with an implantable cardioverter-defibrillator.
    Bracke F; van Gelder B; Dijkman B; Meijer A
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):231-2. PubMed ID: 15632856
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilizing and resuscitating patients with automatic implantable cardioverter-defibrillators.
    Ellis JI
    West J Med; 1993 Nov; 159(5):595-6. PubMed ID: 8279158
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of exhaustion of implantable cardioverter defibrillator therapies due to inappropriate programming.
    Fragakis NK; Antoniadis AP; Geleris P
    Hellenic J Cardiol; 2011; 52(4):354-6. PubMed ID: 21933768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous implantable cardioverter-defibrillator lead erosion after weight loss.
    Pai RK; Cadman CS
    Cardiol Rev; 2005; 13(1):27. PubMed ID: 15596025
    [No Abstract]   [Full Text] [Related]  

  • 17. Chapter 10. Current evidence on the cost effectiveness of the implantable cardioverter defibrillator.
    O'Brien BJ; Yee R
    Can J Cardiol; 2000 Jun; 16 Suppl C():45C-7C. PubMed ID: 10887279
    [No Abstract]   [Full Text] [Related]  

  • 18. Phantom shock in a patient with an implantable cardioverter defibrillator: case report.
    Prudente LA
    Am J Crit Care; 2003 Mar; 12(2):144-6. PubMed ID: 12625172
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure of an implantable cardioverter defibrillator to terminate ventricular tachycardia: why?
    Conti L; Tran N; Burri H; Zimmermann M
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):228-30. PubMed ID: 19821932
    [No Abstract]   [Full Text] [Related]  

  • 20. Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator.
    Vollmann D; Lüthje L; Vonhof S; Unterberg C
    Heart Rhythm; 2005 Mar; 2(3):307-9. PubMed ID: 15851324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.